NCT07600931 Assessment of LVOT VTI in Healthy Volunteers
| NCT ID | NCT07600931 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Medical University of Warsaw |
| Condition | Hemodynamic Assessment |
| Study Type | OBSERVATIONAL |
| Enrollment | 30 participants |
| Start Date | 2026-05-11 |
| Primary Completion | 2026-12-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 30 participants in total. It began in 2026-05-11 with a primary completion date of 2026-12-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Healthy subjects will have transthoracic echocardiography evaluation of Left Ventricular Outflow Tract Velocity-Time Integral (LVOT VTI) performed by operators after brief training.
Eligibility Criteria
Inclusion Criteria: * Age \> 18 years, * Medical student at Medical University of Warsaw or licensed physician. Exclusion Criteria: * Age \< 18 years, * Prior experience in performing cardiac ultrasound examinations, including acquisition of apical five- and three-chamber views and Doppler measurements of LVOT VTI.
Contact & Investigator
Julia Trzebicka, MD
PRINCIPAL INVESTIGATOR
Medical University of Warsaw
Frequently Asked Questions
Who can join the NCT07600931 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Hemodynamic Assessment. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07600931 currently recruiting?
Yes, NCT07600931 is actively recruiting participants. Visit ClinicalTrials.gov or contact Medical University of Warsaw to inquire about joining.
Where is the NCT07600931 trial being conducted?
This trial is being conducted at Warsaw, Poland.
Who is sponsoring the NCT07600931 clinical trial?
NCT07600931 is sponsored by Medical University of Warsaw. The principal investigator is Julia Trzebicka, MD at Medical University of Warsaw. The trial plans to enroll 30 participants.